Reuters Health adds executive editor

Share this article:
Reuters Health hired Ivan Oransky as executive editor, heading editorial operations for the company's global medical and healthcare news services.

The appointment became effective June 15.

“Joining Reuters Health is a great opportunity to lead a talented team that has built a highly authoritative, comprehensive and successful news service over the years,” Oransky told the Association of Health Care Journalists (AHCJ). Oransky was elected to the AHCJ's board in 2002.

Vincent Baby, VP of news services for Reuters News Agency, said in a statement that Oransky's academic and professional track record “make him the ideal person to develop Reuters Health and further leverage the unique assets of Thomson Reuters in the scientific and healthcare arena for the benefit of our professional and media customers.”

Oransky was previously an online managing editor at Scientific American, where he oversaw “significant content expansion and high traffic growth,” according to a statement.

In addition to AHCJ, Oransky is also a member of the National Association of Science Writers.

The move follows the planned retirement of Robert Saunders, who has been at the editorial helm of Reuters Health for over 10 years.

“Saunder's significant contributions and strategic leadership have helped build Reuters Health over the past decade,” said Baby.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?